154 related articles for article (PubMed ID: 1824826)
21. Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.
Damon LE; Christensen S; Rochlitz C; Cadman EC
Anticancer Res; 1989; 9(6):1761-7. PubMed ID: 2534035
[TBL] [Abstract][Full Text] [Related]
22. Sensitization of 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin cytotoxicity by 5-bromo-2'-deoxyuridine in human glioma.
Mancini WR; Glaze ER; Stetson PL; Greenberg HS
J Pharmacol Exp Ther; 1999 Jun; 289(3):1404-9. PubMed ID: 10336533
[TBL] [Abstract][Full Text] [Related]
23. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
Davis ST; Berger SH
Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
[TBL] [Abstract][Full Text] [Related]
25. PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.
Yang JL; Fernandes DJ; Wheeler KT; Capizzi RL
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1073-9. PubMed ID: 8600090
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric enumeration of drug-resistant tumor cells.
deFazio A; Musgrove EA; Tattersall MH
Cancer Res; 1988 Nov; 48(21):6037-43. PubMed ID: 3167854
[TBL] [Abstract][Full Text] [Related]
27. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment.
Takagi S; McFadden ML; Humphreys RE; Woda BA; Sairenji T
Cytometry; 1993; 14(6):640-8. PubMed ID: 8404370
[TBL] [Abstract][Full Text] [Related]
28. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
29. Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.
Knol JA; Walker SC; Robertson JM; Yang Z; DeRemer S; Stetson PL; Ensminger WD; Lawrence TS
Cancer Res; 1995 Sep; 55(17):3687-91. PubMed ID: 7641176
[TBL] [Abstract][Full Text] [Related]
30. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.
Sobrero AF; Moir RD; Bertino JR; Handschumacher RE
Cancer Res; 1985 Jul; 45(7):3155-60. PubMed ID: 3159474
[TBL] [Abstract][Full Text] [Related]
31. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
[TBL] [Abstract][Full Text] [Related]
33. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.
Ashour OM; Naguib FN; Khalifa MM; Abdel-Raheem MH; Panzica RP; el Kouni MH
Cancer Res; 1995 Mar; 55(5):1092-8. PubMed ID: 7866994
[TBL] [Abstract][Full Text] [Related]
35. Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) cells: relevance to cell growth inhibition.
Yin MB; Rustum YM
Cancer Commun; 1991 Feb; 3(2):45-51. PubMed ID: 1825284
[TBL] [Abstract][Full Text] [Related]
36. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
[TBL] [Abstract][Full Text] [Related]
37. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
[TBL] [Abstract][Full Text] [Related]
38. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
[TBL] [Abstract][Full Text] [Related]
39. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
Ingraham HA; Tseng BY; Goulian M
Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
[TBL] [Abstract][Full Text] [Related]
40. [In vitro study on intrathecal application of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant tumor].
Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
No Shinkei Geka; 1998 Sep; 26(9):787-94. PubMed ID: 9757455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
